Bone marrow mesenchymal stem cell-derived exosomal miR-21 protects C-kit+ cardiac stem cells from oxidative injury through the PTEN/PI3K/Akt axis.

Cited by papers we hold 8

• Extracellular Vesicles under Oxidative Stress Conditions: Biological Properties and Physiological Roles · 2021
  No notice
• Development of Extracellular Vesicle Therapeutics: Challenges, Considerations, and Opportunities · 2021
  No notice
• Functional assays to assess the therapeutic potential of extracellular vesicles · 2020
  No notice
• Mesenchymal stem cell-derived exosomes ameliorate cardiomyocyte apoptosis in hypoxic conditions through microRNA144 by targeting the PTEN/AKT pathway · 2020
  No notice
• Exosomes derived from microRNA-138-5p-overexpressing bone marrow-derived mesenchymal stem cells confer neuroprotection to astrocytes following ischemic stroke via inhibition of LCN2 · 2019
  Corrected
• Exosomal circHIPK3 Released from Hypoxia-Pretreated Cardiomyocytes Regulates Oxidative Damage in Cardiac Microvascular Endothelial Cells via the miR-29a/IGF-1 Pathway · 2019
  No notice
• Enhancement of therapeutic potential of mesenchymal stem cell-derived extracellular vesicles · 2019
  No notice
• Mesenchymal stem cell-derived extracellular vesicles affect disease outcomes via transfer of microRNAs · 2018
  No notice

Questions about this paper

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.